Search
Close
Search
Advanced Search
Search Menu
Pregnancy, pulmonary vascular disease, Eisenmenger's syndrome, primary pulmonary hypertension, secondary pulmonary hypertension, mitral valve stenosis
f1

Correspondence: Branko M. Weiss, MD, Department of Anaesthesiology, University Hospital, Rämistrasse 100, CH-8091 Zurich, Switzerland.

References

1

Robson
SC
, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy.
Am J Physiol
.
1989
;
256
:
H1060
–H1065

2

Capeless
EL
, Clapp JF. Cardiovascular changes in early phase of pregnancy.
Am J Obstet Gynecol
.
1989
;
161
:
1449
–1453

3

Phippard
AF
, Horvath JS, Glynn EM. Circulatory adaptation to pregnancy—serial studies of haemodynamics, blood volume, renin and aldosterone in the baboon (Papio hamadryas).
J Hypertens
.
1986
;
4
:
773
–779

4

Schrier
RW
, Durr JA. Pregnancy: an overfill or underfill state.
Am J Kidney Dis
.
1987
;
9
:
284
–289

5

Chapman
AB
, Abraham WT, Zamudio S. Temporal relationship between hormonal and hemodynamic changes in early human pregnancy.
Kidney Int
.
1998
;
54
:
2056
–2063

6

Duvekot
JJ
, Peeters LLH. Maternal cardiovascular hemodynamic adaptation to pregnancy.
Obstet Gynecol Surv
.
1994
;
49
:
S1
–S14

7

Bonica
JJ
. Maternal anatomic and physiologic alterations during pregnancy and parturition. Bonica JJ, McDonald JS. Practice of Obstetric Analgesia and Anesthesia. Baltimore: Williams & Wilkins; 1995. p. 45–82

8

Poppas
A
, Shroff SG, Korcarz CE. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load.
Circulation
.
1997
;
95
:
2407
–2415

9

van Oppen
ACC
, Stigter RH, Bruinse HW. Cardiac output in normal pregnancy: a critical review.
Obstet Gynecol
.
1996
;
87
:
310
–318

10

Mone
SM
, Sanders SP, Colan SD. Control mechanisms for physiological hypertrophy of pregnancy.
Circulation
.
1996
;
94
:
667
–672

11

Robson
SC
, Hunter S, Boys RJ, Dunlop W. Serial changes in pulmonary haemodynamics during human pregnancy: a non-invasive study using Doppler echocardiography.
Clin Sci Colch
.
1991
;
80
:
113
–117

12

Hunter
S
, Robson SC. Adaptation of the maternal heart in pregnancy.
Br Heart J
.
1992
;
68
:
540
–543

13

Robson
SC
, Hunter S, Moore M, Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study.
Br J Obstet Gynaecol
.
1987
;
94
:
1028
–1029

14

Clapp
JF
3rd , Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies.
Am J Cardiol
.
1997
;
80
:
1469
–1473

15

Hankins
GDV
, Clark SL, Uckran E, Van Hook JW. Maternal oxygen transport variables during the third trimester of normal pregnancy.
Am J Obstet Gynecol
.
1999
;
180
:
406
–409

16

Weiss
BM
, Biro P. Kardiovaskuläre Erkrankungen. Alon E. Anästhesie und Schmerzlinderung in der Geburtshilfe. Bern: Hans Huber; 1996. p. 192–222

17

Lewis, G, Drife, J, Botting, B, Why mothers die, London, Department of Health and Her Majesty's Stationery Office, 1998

18

Avila
WS
, Grinberg M. Gestaçāo em portadoras de afecçōes cardiovasculare. Experiênca com 1000 casos.
Arq Bras Cardiol
.
1993
;
60
:
5
–11

19

Presbitero
P
, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus.
Circulation
.
1994
;
89
:
2673
–2676

20

Meyer
NE
, Mercer B, Khoury A, Sibai B. Pregnancy complicated by cardiac disease. Maternal and perinatal outcome.
J Maternal-Fetal Med
.
1994
;
3
:
31
–36

21

McCaffrey
FM
, Sherman FS. Pregnancy and congenital heart disease; the Magee-Women's Hospital.
J Maternal-Fetal Med
.
1995
;
4
:
152
–159

22

Oliveira
TA
, Avila WS, Grinberg M. Obstetric and perinatal aspects in patients with congenital heart disease.
Rev Paul Med
.
1996
;
114
:
1248
–1254

23

Chia
YT
, Yeoh SC, Viegas OA, Lim M, Ratnam SS. Maternal congenital heart disease and pregnancy outcome.
J Obstet Gynaecol Res
.
1996
;
22
:
185
–191

24

Siu
SC
, Sermer M, Harrison DA. Risk and predictors for pregnancy-related complications in women with heart disease.
Circulation
.
1997
;
96
:
2789
–2794

25

Gleicher
N
, Midwall J, Hochberger D, Jaffin H. Eisenmenger's syndrome and pregnancy.
Obstet Gynecol Surv
.
1979
;
34
:
721
–741

26

Sbarouni
E
, Oakley CM. Outcome of pregnancy in women with valve protheses.
Br Heart J
.
1994
;
71
:
196
–201

27

Canobbio
MM
, Mair DD, van der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair.
J Am Coll Cardiol
.
1996
;
28
:
763
–767

28

Neumayer
U
, Somerville J. Outcome of pregnancies in patients with complex pulmonary atresia.
Heart
.
1997
;
78
:
16
–21

29

Dore
A
, Somerville J. Pregnancy in patients with pulmonary autograft valve replacement.
Eur Heart J
.
1997
;
18
:
1659
–1662

30

Weiss
BM
, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996.
J Am Coll Cardiol
.
1998
;
31
:
1650
–1657

31

Arora
R
, Kalra GS, Murty GSR. Percutaneous transatrial mitral commissurotomy: immediate and intermediate results.
J Am Coll Cardiol
.
1994
;
23
:
1327
–1332

32

Weiss
BM
, von Segesser LK, Alon E, Seifert B, Turina MI. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996.
Am J Obstet Gynecol
.
1998
;
179
:
1643
–1653

33

Grossman
W
, Braunwald E. Pulmonary hypertension. Braunwald E. Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders; 1992. p. 790–816

34

Hopkins
WE
, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.
J Heart Lung Transplant
.
1996
;
15
:
100
–105

35

Somerville
J
. How to manage the Eisenmenger syndrome.
Int J Cardiol
.
1998
;
63
:
1
–8

36

Carabello
BA
, Crawford FA Jr. Valvular heart disease.
N Engl J Med
.
1997
;
337
:
32
–41

37

Mandinov, L, Aeschbacher, B, Hess, OM, Mitral valve disease, Dalla-Volta, S, Bayes de Luna, A, Brochier, M, Cardiology, New York, McGraw-Hill, 1999, 9, 1, 14

38

Alpert
MA
, Goldberg SH, Singsen BH. Cardiovascular manifestations of mixed connective tissue disease in adults.
Circulation
.
1983
;
68
:
1182
–1193

39

Morgan
JM
, Griffiths M, du Bois RM, Evans TW. Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension.
Chest
.
1991
;
99
:
551
–556

40

Abenheim
L
, Moride Y, Brenot F. Appetite-suppressant drugs and the risk of primary pulmonary hypertension.
N Engl J Med
.
1996
;
335
:
609
–616

41

Petitpretz
P
, Brenot F, Azarian R. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.
Circulation
.
1994
;
89
:
2722
–2727

42

Opravil
M
, Pechere M, Speich R. HIV-associated primary pulmonary hypertension. A case control study.
Am J Respir Crit Care Med
.
1997
;
155
:
990
–995

43

Elstein
D
, Klutstein MW, Lahad A, Abrahamov A, Hadas-Halpern I, Zimran A. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease.
Lancet
.
1998
;
351
:
1544
–1546

44

Gaine
SP
, Rubin LJ. Primary pulmonary hypertension.
Lancet
.
1998
;
352
:
719
–725

45

McLaughlin
VV
, Rich S. Pulmonary hypertension— advances in medical and surgical interventions.
J Heart Lung Transpl
.
1998
;
17
:
739
–743

46

Penny
WF
, Weinstein M, Saltzman EW, Ware JA. Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics.
Circulation
.
1991
;
83
:
1630
–1636

47

Lopes
AA
, Maeda NY, Bydlowski SP. Abnormalities in circulating von Willebrand factor and survival in pulmonary hypertension.
Am J Med
.
1998
;
105
:
21
–26

48

Wood
P
. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt.
Br Med J
.
1958
;
2
:
701
–709

49

Collins-Nakai
RL
, Rabinovitch M. Pulmonary vascular obstructive disease.
Cardiol Clin
.
1993
;
11
:
675
–687

50

Kidd
L
, Driscoll DJ, Gersony WM. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects.
Circulation
.
1993
;
87
:
I-38
–I-51

51

Saha
A
, Balakrishnan KG, Jaiswal PK. Prognosis for patients with Eisenmenger syndrome of various aetiology.
Int J Cardiol
.
1994
;
45
:
199
–207

52

Daliento
L
, Somerville J, Presbitero P. Eisenmenger syndrome. Factors relating to deterioration and death.
Eur Heart J
.
1998
;
19
:
1845
–1855

53

Niwa
K
, Perioff JK, Kaplan S, Child JS, Miner PD. Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart.
J Am Coll Cardiol
.
1999
;
34
:
223
–232

53

Smedstad
K
, Cramb R, Morison DH. Pulmonary hypertension and pregnancy: a series of eight cases.
Can J Anaesth
.
1994
;
41
:
502
–512

54

Avila
WS
, Grinberg M, Snitcowsky R. Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome.
Eur Heart J
.
1995
;
16
:
460
–464

55

Tahir
H
. Pulmonary hypertension, cardiac disease and pregnancy.
Int J Gynecol Obstet
.
1995
;
51
:
109
–113

56

Bosatra
MG
, Passarani S, Marino MR, Marcolin R, Fumagalli R, Pesenti A. Caesarean delivery of a patient with truncus arteriosus.
Int J Obstet Anesth
.
1997
;
6
:
279
–284

57

Goldsmith
RJ
, Henderson JL, Reynolds JD, Penning DH. Management of a parturient with an uncorrected atrioventricular canal defect.
Int J Obstet Anesth
.
1998
;
7
:
181
–184

58

Goodwin
TM
, Gherman RB, Hameed A, Eikayam U. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy.
Am J Obstet Gynecol
.
1999
;
180
:
64
–67

59

Yentis
SM
, Steer PJ, Plaat F. Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990's.
Br J Obstet Gynaecol
.
1998
;
105
:
921
–922

60

Wight
E
, Noll G, Lüscher TF. Regulation of vascular tone and endothelial function and its alterations in cardiovascular disease.
Baillière's Clin Anaesth
.
1997
;
11
:
531
–560

61

Christman
BW
, McPherson CD, Newman JH. An imbalance of the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
N Engl J Med
.
1992
;
327
:
70
–75

62

Giaid
A
, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.
N Engl J Med
.
1995
;
333
:
214
–221

63

Rabinovitch
M
. Novel mediators of pulmonary vascular pathobiology. Schwinn DA. New Advances in Vascular Biology and Molecular Cardiovascular Medicine. Baltimore: Williams & Wilkins; 1998. p. 49–68

64

Cool
CD
, Kenedy D, Voelkel NF, Tuder RM. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection.
Hum Pathol
.
1997
;
28
:
434
–442

65

Hassell
KL
. Altered hemostasis in pulmonary hypertension.
Blood Coagul Fibrinolysis
.
1998
;
9
:
107
–117

66

Williamson
DJ
, Hayward C, Rogers P. Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension.
Circulation
.
1996
;
94
:
477
–482

67

Hinderliter
AL
, Willis PW IV, Barst RJ. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension.
Circulation
.
1997
;
95
:
1479
–1486

68

McLaughlin
VV
, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
N Engl J Med
.
1998
;
338
:
273
–277

69

Rich
S
. Clinical insights into the pathogenesis of primary pulmonary hypertension.
Chest
.
1998
;
114
:
237S
–241S

70

Lee
SD
, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.
J Clin Invest
.
1998
;
101
:
927
–934

71

Endrys
J
, Hayat N, Cherian G. Comparison of brochopulmonary collaterals and collateral blood flow in patients with chronic thromboembolic and primary pulmonary hypertension.
Heart
.
1997
;
78
:
171
–176

72

Martinuzzo
ME
, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO. Lupus anticoagulant, high levels of anticardiolipin and anti-β2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.
J Rheumatol
.
1998
;
25
:
1313
–1319

73

Miyata
M
, Suzuki K, Sakuma F. Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus.
Int Arch Allergy Immunol
.
1993
;
100
:
351
–354

74

Ordi-Ros
J
, Perez-Peman P, Monasterio J. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).
Haemostasis
.
1994
;
24
:
165
–174

75

Roldan
CA
, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus.
N Engl J Med
.
1996
;
335
:
1424
–1430

76

Hojnik
M
, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.
Circulation
.
1996
;
93
:
1579
–1587

77

Glanville
AR
, Burke CM, Theodore J, Robin ED. Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation.
Chest
.
1987
;
91
:
675
–681

78

Brenot
F
. Primary pulmonary hypertension. Case series from France.
Chest
.
1994
;
105
:
33S
–36S

79

Rozkovec
A
, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension.
Br Heart J
.
1986
;
55
:
449
–458

80

Sagie
A
, Freitas N, Padial LR. Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: valve area and right heart disease.
J Am Coll Cardiol
.
1996
;
28
:
472
–479

81

Fawzy
ME
, Mimish L, Sivanandam V. Immediate and long-term effect of mitral balloon valvotomy on severe pulmonary hypertension in patients with mitral stenosis.
Am Heart J
.
1996
;
131
:
89
–93

82

Sugishita
Y
, Ito I, Kubo T. Pregnancy in cardiac patients: possible influence of volume overload by pregnancy on pulmonary circulation.
Jpn Circ J
.
1986
;
50
:
376
–383

83

Avila
WS
, Grinberg M, Decourt LV, Bellotti G, Pileggi F. Evoluçao clinica de portadoras de estenose mitral no ciclo gravidico-puerperal.
Arq Bras Cardiol
.
1992
;
58
:
359
–364

84

Ziskind
Z
, Etchin A, Frenkel Y. Epidural anesthesia with the Trendelenburg position for Caesarean section with or without a cardiac surgical procedure in patients with severe mitral stenosis: a hemodynamic study.
J Cardiothorac Anesth
.
1990
;
4
:
354
–359

85

Hemmings
GT
, Whalley DG, O'Connor PJ, Benjamin A, Dunn C. Invasive monitoring and anaesthetic management of a parturient with mitral stenosis.
Can J Anaesth
.
1987
;
34
:
182
–185

86

Ducey
JP
, Ellsworth SM. The hemodynamic effects of severe mitral stenosis and pulmonary hypertension during labor and delivery.
Intensive Care Med
.
1989
;
15
:
192
–195

87

Al Kasab
S
, Sabag T, Al Zaibag M. β-Adrenergic receptor blockade in the management of pregnant women with mitral stenosis.
Am J Obstet Gynecol
.
1990
;
163
:
37
–40

88

Afrangui
B
, Malinow AM. Severe preclampsia complicating mitral valve stenosis.
Reg Anesth Pain Med
.
1998
;
23
:
204
–209

89

Sia
ATH
, Chong JL, Tan CGM. Severe mitral stenosis in a parturient with congestive cardiac failure and hypoglycaemia.
Int J Obstet Anesth
.
1998
;
7
:
173
–176

90

Batson
MA
, Longmire S, Csontos E. Alfentanil for urgent Caesarean section in a patient with severe mitral stenosis and pulmonary hypertension.
Can J Anaesth
.
1990
;
37
:
685
–688

91

Lenoir
B
, Freiermuth C, Bonnet A, Marty J. Césarienne, maladie mitrale et hypertension artérielle pulmonaire. Implications du monitorage hémodynamique sur la conduite de l'anesthesie.
Ann Fr Anesth Réanim
.
1993
;
12
:
582
–586

92

Weiss, BM, Rhomberg, P, Fehr, S, Pregnant patient with mitral stenosis 1989–1998

93

Stephen
SJ
. Changing patterns of mitral stenosis in childhood and pregnancy in Sri Lanka.
J Am Coll Cardiol
.
1992
;
19
:
1276
–1284

94

Esteves
CA
, Ramos AI, Braga SL, Harrison JK, Sousa JE. Effectiveness of percutaneous balloon mitral valvotomy during pregnancy.
Am J Cardiol
.
1991
;
68
:
930
–934

95

Sananes
S
, Iung B, Vahanian A, Acar J, Salat-Baroux J, Uzan S. Fetal and obstetrical impact of percutaneous balloon mitral commissurotomy during pregnancy.
Fetal Diagn Ther
.
1994
;
9
:
218
–225

96

Gupta
A
, Lokhandwala YY, Satoskar PR, Salvi VS. Balloon mitral valvotomy in pregnancy: maternal and fetal outcomes.
J Am Coll Surg
.
1998
;
187
:
409
–415

97

Martinez-Reding
J
, Cordero A, Kuri J, Martinez-Rios MA, Salazar E. Treatment of severe mitral stenosis with percutaneous balloon valvotomy in pregnant patients.
Clin Cardiol
.
1998
;
21
:
659
–663

98

Gupta
S
, Vora A, Lokhandwalla Y. Percutaneous balloon mitral valvotomy in mitral restenosis.
Eur Heart J
.
1996
;
17
:
1560
–1564

99

Oakley
CM
. Anticoagulants in pregnancy.
Br Heart J
.
1995
;
74
:
107
–111

100

Barbour
LA
, Pickard J. Controversies in thromboembolic disease during pregnancy: a critical review.
Obstet Gynecol
.
1995
;
86
:
621
–633

101

Astedt . Antenatal drugs affecting vitamin K status of the fetus and the newborn.

Semin Thromb Hemost
.
1995
;
21
:
364
–370

102

Greer
IA
. Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology.
Baillière's Clin Obstet Gynaecol
.
1997
;
11
:
403
–430

103

Bates
SM
, Ginsberg JS. Anticoagulants in pregnancy: fetal effects.
Baillière's Clin Obstet Gynaecol
.
1997
;
11
:
479
–488

104

Koren
G
, Pastuszak A, Ito S. Drugs in pregnancy.
N Engl J Med
.
1998
;
338
:
1128
–1137

105

Ginsberg
JS
, Hirsh J. Use of antithrombotic agents during pregnancy.
Chest
.
1998
;
114
:
524S
–530S

106

Dulitzky
M
, Pauzner R, Langevitz P, Pras M, Many A, Schiff E. Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies.
Obstet Gynecol
.
1996
;
87
:
380
–383

107

Nelson-Piercy
C
, Letsky EA, de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-one pregnancies in sixty-one women at high risk.
Am J Obstet Gynecol
.
1997
;
176
:
1062
–1068

108

LéCuru
F
, Desnos M, Taurelle R. Anticoagulant therapy in pregnancy: report of 54 cases.
Acta Obstet Gynecol Scand
.
1996
;
75
:
217
–221

109

Nelson-Piercy
C
. Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis.
Baillière's Clin Obstet Gynaecol
.
1997
;
11
:
489
–509

110

Macklon
NS
, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy.
Br J Obstet Gynaecol
.
1997
;
104
:
191
–197

111

Sharma
SK
, Phillip J, Wiley J. Thromboelastographic changes in healthy parturients and postpartum women.
Anesth Analg
.
1997
;
85
:
94
–98

112

Bellart
J
, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
Am J Perinatol
.
1998
;
15
:
81
–85

113

Letsky
EA
. Peripartum prophylaxis of thrombo-embolism.
Baillière's Clin Obstet Gynaecol
.
1997
;
11
:
523
–543

114

Grubb
NR
, Bloomfield P, Ludlam CA. The end of the heparin pump? Low molecular weight heparin has many advantages over unfractionated heparin (editorial).
BMJ
.
1998
;
317
:
1540
–1542

115

Beilin
Y
, Zahn J, Comerford M. Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000mm−3.
Anesth Analg
.
1997
;
85
:
385
–388

116

Horlocker
TT
, Wedel DK. Anticoagulation and neuroaxial block: historical perspective, anesthetic implications, and risk management.
Reg Anesth Pain Med
.
1998
;
23
:
129
–134

117

Perloff
JK
. Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism.
Cardiol Clin
.
1993
;
11
:
689
–699

118

Haroutunian
LM
, Neill CA. Pulmonary complications of congenital heart disease: hemoptysis.
Am Heart J
.
1972
;
84
:
540
–559

119

Leung
WH
, Lau CP, Wong CK, Cheng CH. Fatal massive pulmonary hemorrhage complicating mitral stenosis.
Clin Cardiol
.
1990
;
13
:
136
–138

120

Waring
PH
, Shaw DB, Brumfield CG. Anesthetic management of a parturient with Osler-Weber-Rendu syndrome and rheumatic heart disease.
Anesth Analg
.
1990
;
71
:
96
–99

121

Downs
TW
, Chao CR. Massive hemoptysis in pregnancy treated with bronchial embolization.
Am J Perinatol
.
1997
;
14
:
51
–53

122

Leonard
H
, O'Sullivan JJ, Hunter S. Family planning requirements in the adult congenital heart disease clinic.
Heart
.
1996
;
76
:
60
–62

123

Tio
I
, Tewari K, Balderston KD, Milliken JC, Porto M. Emergency mitral valve replacement in the setting of severe pulmonary hypertension and acute cardiovascular decompensation after evacuation of twins at fifteen weeks' gestation.
Am J Obstet Gynecol
.
1998
;
179
:
270
–272

124

Popijn
M
, Hensenne A, Gibon M. Hypertension artérielle pulmonaire primitive et grossesse. Á propos d'une observation.
J Gynecol Obstet Reprod Biol
.
1991
;
20
:
691
–694

125

Raines
DE
, Liberthson RR, Murray JR. Anesthetic management and outcome following noncardiac surgery in nonparturients with Eisenmenger's physiology.
J Clin Anesth
.
1996
;
8
:
341
–347

126

Myles
PS
. Anaesthetic management of laparoscopic sterilisation and termination of pregnancy in a patient with severe primary pulmonary hypertension.
Anaesth Intens Care
.
1994
;
22
:
465
–469

127

Temelcos
C
, Kuhn R, Stribley C. Sterilization of women with Eisenmenger syndrome: report of 4 cases.
Aust NZ J Obstet Gynaecol
.
1997
;
37
:
121
–123

128

Weiss
BM
, Atanassoff PG, Jenni R, Walder B, Wight E. Pulmonary atresia with ventricular septal defect: a case for central venous pressure and oxygen saturation monitoring.
Yale J Biol Med
.
1998
;
71
:
15
–21

130

Ammash
NM
, Connolly HM, Abel MD, Warnes CA. Noncardiac surgery in Eisenmenger syndrome.
J Am Coll Cardiol
.
1999
;
33
:
222
–227

129

Kerstein
D
, Levy PS, Hsu DT, Hordorf AJ, Gersony WM, Barst RJ. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension.
Circulation
.
1995
;
91
:
2028
–2035

130

Sandoval
J
, Gaspar J, Pulido T. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment.
J Am Coll Cardiol
.
1998
;
32
:
297
–304

131

Moser
KM
, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment.
Eur Respir J
.
1992
;
5
:
334
–342

132

Johnson
MR
, Naftel DC, Hobbs RE. The incremental risk of female sex in heart transplantation: a multiinstutitional study of peripartum cardiomyopathy and pregnancy. Cardiac Transplant Research Database Group.
J Heart Lung Transpl
.
1997
;
16
:
801
–812

133

Chinayon
P
, Sakornpant P. Successful pregnancy after heart-lung transplantation.
Asia Oceania J Obstet Gynaecol
.
1994
;
20
:
275
–278

134

Troche
V
, Ville Y, Fernandez H. Pregnancy after heart or heart-lung transplantation: a series of 10 pregnancies.
Br J Obstet Gynaecol
.
1998
;
105
:
454
–458

135

Inbar
S
, Schrader BJ, Kaufmann E, Vestal RE, Rich S. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
J Am Coll Cardiol
.
1993
;
21
:
413
–418

135a

Friedman
R
, Mears JG, Barst RJ. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension.
Circulation
.
1997
;
96
:
2782
–2784

136

Kunimoto
F
, Arai K, Isa Y. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome.
Anesth Analg
.
1997
;
85
:
507
–513

137

Girard
C
, Lefot JJ, Pannetier JC, Filley S, Ffrench P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension.
Anesthesiology
.
1992
;
77
:
880
–883

138

Olschewski
H
, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Ann Intern Med
.
1996
;
124
:
820
–824

139

Mikhail
G
, Gibbs JSR, Richardson M. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
Eur Heart J
.
1997
;
18
:
1499
–1504

140

Gildein
HP
, Wildberg A, Mocellin R. Vergleichende Untersuchungen der Hämodynamik unter Prostazyklin und Nifedipin bei Patienten mit Eisenmenger-Syndrom.
Z Kardiol
.
1995
;
84
:
55
–63

144

Atz
AM
, Adatia I, Lock JE, Wesel DL. Combined effects of nitric oxide and oxygen during acute pulmonary vascular testing.
J Am Coll Cardiol
.
1999
;
33
:
813
–819

140b

Rozenzweig
EB
, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
Circulation
.
1999
;
99
:
1858
–1865

141

Castro
PF
, Bourge RC, McGiffin DC. Intrapulmonary shunting in primary pulmonary hypertension. An observation in two patients treated with epoprostenol sodium.
Chest
.
1998
;
114
:
334
–336

142

Gries
A
, Bode C, Peter K. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo.
Circulation
.
1998
;
97
:
1481
–1487

143

Wanecek
M
, Rudehill A, Hemsen A, Lundberg JM, Weitzberg E. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
Crit Care Med
.
1997
;
25
:
848
–857

144

Holm
P
, Liska J, FrancoCereceda A. The ATA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.
Cardiovasc Res
.
1998
;
37
:
765
–771

145

Dupuis
J
, Cernacek P, Tardif JC. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension.
Am Heart J
.
1998
;
135
:
614
–620

146

Giaid
A
. Nitric oxide and endothelin-1 in pulmonary hypertension.
Chest
.
1998
;
114
:
208S
–212S

147

N Engl J Med
.
1999
;
340
:
455
–464

148

Robinson
JN
, Banerjee R, Landzberg MJ, Thiet MP. Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension.
Am J Obstet Gynecol
.
1999
;
180
:
64
–67

149

Easterling
TR
, Ralph DD, Schmucker BC. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators.
Obstet Gynecol
.
1999
;
93
:
494
–498

150

O'Hare
R
, McLoghlin C, Milligan K, McNamee D, Sidhu H. Anaesthesia for Caesarean section in the presence of severe primary pulmonary hypertension.
Br J Anaeth
.
1998
;
81
:
790
–792

Article PDF first page preview

Article PDF first page preview
PDF
This content is only available as a PDF.
The European Society of Cardiology
Topic:
Download all slides